Our Commitment to Patients

At BeOne Medicines “patients first” is more than a core value – it’s our guiding principle. Every day, we strive to create high-quality, innovative medicines faster for patients. It’s not enough for innovative medications to simply exist. We want to make sure patients can access them. We work with cancer communities in the U.S., Europe, Asia and around the globe to learn from patients, their families and their care partners to help improve their lives by identifying and addressing their unmet needs.

We believe in actively involving patients and care partners in our research and development process. This helps us understand the real-life needs and challenges that people living with cancer face. By gaining perspectives from patients and their care partners, we can design clinical trials to reflect their needs and with outcomes that matter to them.

We also strive to include diverse populations in our research endeavours, with representation for age, ethnicities, genders, abilities and geographies, wherever possible. Medications don’t always work the same for everyone, so studying outcomes in diverse patient groups can help us develop medications that meet the needs of more patients.

To learn more, visit our “Clinical trials” page, where you can find out if you may be eligible to participate. Please consult with your doctor to discuss if a clinical trial is right for you.

As part of BeOne Medicines’ mission to put patients first, we actively engage with patients and advocacy organisations to help better understand their cancer journey, and close gaps in education, diagnosis, and improve access. We believe in partnering with the patient community to help meet the needs of cancer patients and their care partners. By supporting patient organisations, we help to support and co-create solutions that empower patients and help to improve health outcomes. Through that work, we not only support important programmes, but also incorporate key learnings from patient communities into our strategies and decisions. Our goal is to continue to make our medicines more accessible to people impacted by cancer.

We believe in providing the latest disease and treatment information to help patients and their care partners understand and actively engage in treatment decisions with their healthcare providers. Here’s where you can learn more about our research in oncology.